Skip to Main Content

Paper Details

Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients.
Br J Cancer
8
2022
Author NameAffiliation
Deborah A NickersonUniversity of Washington
Deborah A NickersonUniversity of Washington
Nancy J CoxVanderbilt Genetics Institute, Vanderbilt University Medical Center
Nancy J CoxVanderbilt Genetics Institute, Vanderbilt University Medical Center
Karen L MohlkeUniversity of North Carolina
  • 1 - 5

Datasets

Release 1.2